Webinar – Bispecific Antibodies in Cancer Care: What to Know, What to Expect

Cancer Nation’s Webinar Series presents Bispecific Antibodies in Cancer Care: What to Know, What to Expect, with Tara Graff, DO, MS. Bispecific antibodies are a newer type of immunotherapy cancer treatment, currently more often used in later lines of therapy, mainly in blood cancers such as lymphomas and myelomas. This discussion will help patients and caregivers make sense of Bispecific antibodies — what they are, how they’re used in real-world cancer care, and what people can expect during the early phases of treatment.

Dr. Graff, Director of Clinical Research at Mission Cancer and Blood in Iowa, breaks down common symptoms and side effects, how treatment may feel day to day, and how to communicate clearly and confidently with your care team. She also discusses what survivorship may look like after treatment and what questions patients and caregivers may want to ask along the way.